David Dougherty, MD
Infectious Disease · Lexington, KYNPI 1104261445
Payments from drug & device makers
Across 680 payments — averaging $753.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$419K
- GSK$88K
- Insmed, Inc.$1K
- Viiv Healthcare Company$936
- Merck$681
- Shionogi Inc$651
- plus $2K from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 345 | $418,550 |
| GSK | 42 | $88,093 |
| Insmed, Inc. | 49 | $1,121 |
| Viiv Healthcare Company | 57 | $936 |
| Merck | 47 | $681 |
| Shionogi Inc | 23 | $651 |
| La Jolla Pharmaceutical Company | 15 | $536 |
| Astellas Pharma US Inc | 25 | $414 |
| Melinta Therapeutics, LLC | 21 | $380 |
| Paratek Pharmaceuticals, Inc. | 15 | $255 |
| AbbVie(2 entities) | 9 | $246 |
| Aimmune Therapeutics, Inc. | 7 | $123 |
| Tetraphase Pharmaceuticals, Inc. | 3 | $110 |
| Theratechnologies Inc. | 4 | $82 |
| Johnson & Johnson | 5 | $74 |
| Cumberland Pharmaceuticals, Inc. | 3 | $67 |
| Mayne Pharma Commercial LLC | 3 | $55 |
| Pfizer | 3 | $44 |
| Pharming Healthcare, Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Vyera Pharmaceuticals, LLC | 1 | $13 |
How this compares
$512,489 in reported general payments places this provider in the 95th percentile of 100 infectious disease providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Lexington
- Richard GreenbergLexington$18M
- Charles RoseLexington$171K
- Marty AllenLexington$40K
- Daniel RodrigueLexington$37K
- John MeekLexington$12K
- Mark DoughertyLexington$12K
- Andrea BanksLexington$11K
- Takako SchaningerLexington$8K
- Andrew AlexanderLexington$7K
- Elizabeth PiercyLexington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.